The molecular motor myosin plays crucial-roles in contraction and various forms of cell movement and changes in cell shape. Cytokinesis, directed cell migration by chemotaxis, capping of ligand-bound cell surface receptors, morphogenetic changes in cell shape, and muscle contraction are examples of events that clearly involve this motor. In spite of decades of investigations on myosin, the molecular basis of the conversion of the chemical energy of hydrolysis of ATP into mechanical movement is not understood. A new approach was out development of in vitro assays for quantitating myosin movement along actin filaments. In the last grant period, we succeeded in establishing a feedback-enhanced laser trap assay that allows the direct measurement of force and displacement produced by a single myosin molecular pulling on a single actin filament.
The specific aims of this proposal are to continue to develop the laser trap single molecule assay, and to use it and other in vitro assays to examine the mechanical and biochemical parameters of native and mutated forms of the myosin molecule. Our demonstrations that we can use Dictyostelium to express large amounts of functional myosin and soluble fragments that contain the motor domain allow us to combine molecular genetic manipulation of the motor with measurements of its biochemical and mechanical properties. The experimental plan is divided into two parts; 1. Wild type and mutagenized forms of myosin will be expressed in Dictyostelium, purified to homogeneity, and analyzed in vitro using a variety of quantitative biochemical assays, including our in vitro motility assays. 2. A third generation feedback-enhanced laser trap system will be developed to measure, with higher precision than available previously, displacement and force produced by a single myosin molecule, and the duration of the strongly-bound state of the actin-myosin complex. Specific questions for the next grant period are; 1. Does the light chain binding domain of myosin act as a lever arm to produce about 10nm step in motion? 2. Does the gear box zone undergo large changes in structural rearrangements during the ATPase cycle? 3. How do the various domains of the myosin motor 'talk' to one another to effect the chemomechanical energy transduction? 4. How can we improve the feedback-enhanced laser trap system? 5. How will we use the improved feedback-enhanced laser trap system to study myosin function?

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM033289-14
Application #
2391952
Study Section
Biophysical Chemistry Study Section (BBCB)
Project Start
1984-04-01
Project End
2000-03-31
Budget Start
1997-04-01
Budget End
1998-03-31
Support Year
14
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Stanford University
Department
Biochemistry
Type
Schools of Medicine
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Liu, Chao; Kawana, Masataka; Song, Dan et al. (2018) Controlling load-dependent kinetics of ?-cardiac myosin at the single-molecule level. Nat Struct Mol Biol 25:505-514
Trivedi, Darshan V; Adhikari, Arjun S; Sarkar, Saswata S et al. (2018) Hypertrophic cardiomyopathy and the myosin mesa: viewing an old disease in a new light. Biophys Rev 10:27-48
Kawana, Masataka; Sarkar, Saswata S; Sutton, Shirley et al. (2017) Biophysical properties of human ?-cardiac myosin with converter mutations that cause hypertrophic cardiomyopathy. Sci Adv 3:e1601959
Gangadharan, Binnu; Sunitha, Margaret S; Mukherjee, Souhrid et al. (2017) Molecular mechanisms and structural features of cardiomyopathy-causing troponin T mutants in the tropomyosin overlap region. Proc Natl Acad Sci U S A 114:11115-11120
Sung, J; Mortensen, K I; Spudich, J A et al. (2017) How to Measure Load-Dependent Kinetics of Individual Motor Molecules Without a Force-Clamp. Methods Enzymol 582:1-29
Nag, Suman; Trivedi, Darshan V; Sarkar, Saswata S et al. (2017) The myosin mesa and the basis of hypercontractility caused by hypertrophic cardiomyopathy mutations. Nat Struct Mol Biol 24:525-533
Spudich, James A; Aksel, Tural; Bartholomew, Sadie R et al. (2016) Effects of hypertrophic and dilated cardiomyopathy mutations on power output by human ?-cardiac myosin. J Exp Biol 219:161-7
Green, Eric M; Wakimoto, Hiroko; Anderson, Robert L et al. (2016) A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice. Science 351:617-21
Spudich, James A (2015) The myosin mesa and a possible unifying hypothesis for the molecular basis of human hypertrophic cardiomyopathy. Biochem Soc Trans 43:64-72
Mortensen, Kim I; Sung, Jongmin; Flyvbjerg, Henrik et al. (2015) Optimized measurements of separations and angles between intra-molecular fluorescent markers. Nat Commun 6:8621

Showing the most recent 10 out of 101 publications